KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

LifeMD (LFMD) Equity Average (2016 - 2025)

LifeMD filings provide 13 years of Equity Average readings, the most recent being $13.3 million for Q4 2025.

  • On a quarterly basis, Equity Average rose 309.66% to $13.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was $13.3 million, a 309.66% increase, with the full-year FY2025 number at $7.8 million, up 563.66% from a year prior.
  • Equity Average hit $13.3 million in Q4 2025 for LifeMD, up from $2.8 million in the prior quarter.
  • In the past five years, Equity Average ranged from a high of $16.9 million in Q1 2022 to a low of -$121.6 million in Q1 2025.
  • Median Equity Average over the past 5 years was -$3.5 million (2023), compared with a mean of -$13.6 million.
  • Biggest five-year swings in Equity Average: surged 736.21% in 2022 and later plummeted 46654.85% in 2025.
  • LifeMD's Equity Average stood at $1.5 million in 2021, then plummeted by 534.11% to -$6.6 million in 2022, then surged by 47.92% to -$3.4 million in 2023, then crashed by 83.48% to -$6.3 million in 2024, then soared by 309.66% to $13.3 million in 2025.
  • The last three reported values for Equity Average were $13.3 million (Q4 2025), $2.8 million (Q3 2025), and -$116.7 million (Q2 2025) per Business Quant data.